Share
Journal Information
Issue
Vol. 11. Issue 4.Pages 424-611 (July - August 2012)
Hepatology highlights
Concise review
Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice
Andrés Duarte-Rojo, José Trinidad Altamirano, Jordan J. Feld
Ann Hepatol. 2012;11:426-39
Open access
Gut microbiota and nonalcoholic fatty liver disease
Mariana V. Machado, Helena Cortez-Pinto
Ann Hepatol. 2012;11:440-9
Open access
Original article
Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients
Maribel Rodríguez-Torres, Juan Burguera, Deana Hallman, José Rodríguez-Orengo, Michelle Echeandia
Ann Hepatol. 2012;11:450-63
Open access
Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in Egypt
Amr Abdelkader Fateen, Rasha Youssef Shahin, Mohamed Nazmy Farres, Mai Ahmed Eldeeb, Hanaa Ahmed Amer
Ann Hepatol. 2012;11:464-70
Open access
Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation
Chuan Li, Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Ying Yang, Ming-Qing Xu, Wen-Tao Wang, Yong-Gang Wei
Ann Hepatol. 2012;11:471-7
Open access
Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD)
Narendra S. Choudhary, Ajay Duseja, Naveen Kalra, Ashim Das, Radha K. Dhiman, Yogesh K Chawla
Ann Hepatol. 2012;11:478-86
Open access
Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma
Mahmoud A. Khattab, Mohammed Eslam, Yousef I. Mousa, Nosa Ela-adawy, Shimaa Fathy, Mohammed Shatat, Hesham Abd-Aalhalim, Amal Kamal, Mohammed A. Sharawe
Ann Hepatol. 2012;11:487-94
Open access
Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue
Vera Lucia Pannain, José Rodrigo Morais, Osmar Damasceno-Ribeiro, Venâncio Avancini-Alves
Ann Hepatol. 2012;11:495-9
Open access
Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement
Rolf Teschke, Christian Frenzel, Albrecht Wolff, Jutta Herzog, Xaver Glass, Johannes Schulze, Axel Eickhoff
Ann Hepatol. 2012;11:500-12
Open access
Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study
Şehmus Ölmez, Yüksel Gümürdülü, Adnan Tas, Emre Karakoq, Banu Kara, Adem Kidik
Ann Hepatol. 2012;11:513-8
Open access
Can ARFI elastography predict the presence of significant esophageal varices in newly diagnosed cirrhotic patients?
Simona Bota, Ioan Sporea, Roxana Şirli, Mircea Focşa, Alina Popescu, Mirela Dănilă, Mihnea Strain
Ann Hepatol. 2012;11:519-25
Open access
Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment
Robert P. Myers, James N. Hubbard, Abdel Aziz M. Shaheen, Elijah Dixon, Gilaad G. Kaplan
Ann Hepatol. 2012;11:526-35
Open access
Outcomes of choledochal cysts with or without intrahepatic involvement in children after extrahepatic cyst excision and Roux-en-Y hepaticojejunostomy
Kisa Congo, Maria Francelina Lopes, Patricia H Oliveira, Hugo Matos, Susana Basso, Aurelio Reis
Ann Hepatol. 2012;11:536-43
Open access
Editorial
Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative
Fernando Bessone, Nelia Hernandez, Milagros Dávalos, Raymundo Paraná, María I. Schinoni, Maribel Lizarzabal, David Kershenobich, Aurora Loaeza, ... Raúl J. Andrade
Ann Hepatol. 2012;11:544-9
Open access
The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico
Nahum Méndez-Sánchez
Ann Hepatol. 2012;11:550-1
Open access
Images in hepatology
Massive avascular malformations causing life threatening portal hypertension
Aman Arya, Nirmal Kakani, Nabil Hussain, Natasha Chandok
Ann Hepatol. 2012;11:552-3
Open access
Case report
Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage
Sara Messeri, Luca Messerini, Francesco Vizzutti, Giacomo Laffi, Fabio Marra
Ann Hepatol. 2012;11:554-8
Open access
Acute autoimmune hepatitis presenting with peripheral blood eosinophilia
Shoket Chowdry, Erin Rubin, David A. Sass
Ann Hepatol. 2012;11:559-63
Open access
Hepatotoxicity associated with dietary energy supplements: use and abuse by young athletes
Giovanni Avelar-Escobar, Jorge Méndez-Navarro, Nayeli X. Ortiz-Olvera, Guillermo Castellanos, Roberto Ramos, Víctor E. Gallardo-Cabrera, José de Jesús Vargas-Alemán, Óscar Díaz de León, ... Margarita Dehesa-Violante
Ann Hepatol. 2012;11:564-9
Open access
Letter to editor
Pegylated interferon, but not conventional interferon therapy induced severe skin lesions
Zhengxiao Li, Fanpu Ji, Yan Zheng, Jingang An, Zhenhui Peng
Ann Hepatol. 2012;11:570-1
Open access
Idiopathic portal hypertension with multiple hepatic hyperplastic nodules supplied by portal vein
Atsuyuki Ikeda, Ryuichi Kita, Akihiro Nasu, Norihiro Nishijima, Hiroo Matsuo, Toru Kimura, Yukio Osaki, Makoto Ohbu
Ann Hepatol. 2012;11:572-3
Open access
Liver news elsewhere
Atherosclerosis and chronic hepatitis C
Luis D. Carrillo-Córdova, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2012;11:574-5
Open access
Abstracts section index
Abstracts section
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
